Brain zaps guided by MRI aim to quiet PTSD symptoms

NCT ID NCT06449326

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether a non-invasive brain stimulation technique called intermittent theta burst stimulation (iTBS) can reduce chronic PTSD symptoms in veterans. The stimulation is guided by functional MRI scans to target a specific brain region. Half of the 64 participants receive real stimulation, while the other half receive a sham (placebo) version, to see if the treatment truly helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intermittent theta burst stimulation (iTBS) delivered via transcranial magnetic stimulation
What this could lead to
If successful, this could offer a non-drug, targeted brain stimulation treatment for chronic PTSD symptoms in veterans.
What could go wrong
This is a small, early-stage trial (64 participants) with a sham control, so results may not generalize. The treatment is experimental and may not provide lasting relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Veterans will be enrolled in this study if they: 1. are aged 18-80; 2. have a documented diagnosis of PTSD with evidence of ongoing symptoms as demonstrated by score of "31" or higher on the PCL-5, a measure of posttraumatic stress symptoms; 3. are fluent in English (as the neuropsychological testing tools used are only available in English) and 4. have been on stable doses of psychotropic medications for the past month. Exclusion Criteria: * Veterans will be excluded from participation in this study if there is: 1. a prior history of other neurological disease beyond mild TBI, as determined by VA/DoD criteria for TBI severity; 2. any history of seizures beyond immediate posttraumatic seizure or childhood febrile seizure, so as to reduce risk of exacerbation of epilepsy or other neurological symptoms; 3. history of a psychotic disorder, such as schizophrenia or bipolar disorder, so as to reduce risk of psychiatric decompensation; 4. active substance/alcohol dependence without ongoing treatment, to reduce confounding effects on diagnosis and brain imaging; 5. presence of any implanted electrical device (e.g., pacemaker), to reduce risk of device malfunction from rTMS; 6. recent medical hospitalization (within four weeks), to reduce risk of medical decompensation during the study; 7. any condition that would prevent the subject from completing the protocol; 8. appointment of a legal representative or inability to provide informed consent, to avoid coercion of a vulnerable population; 9. any ongoing litigation related to PTSD, TBI, disability determination, or service connection, to prevent interference with legal proceedings; 10. any contraindication to MRI; 11. pregnant women, so as to prevent complications; 12. membership in an identified vulnerable population, including minors and prisoners, so as to prevent coercion; 13. Cognitively impaired adults who lack capacity to consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Posttraumatic stress disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • New Mexico VA Health Care System

    RECRUITING

    Albuquerque, New Mexico, 87108, United States

  • UNM Center for Psychiatric Research

    RECRUITING

    Albuquerque, New Mexico, 87106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.